FTRE Profile
Fortrea Holdings Inc., based in Durham, North Carolina, is a global contract research organization (CRO) specializing in the comprehensive development of biopharmaceutical products and medical devices. Established in 2023, the company offers a broad range of services designed to support and accelerate the development of new therapies and technologies across the healthcare industry.
Fortrea Holdings operates through two primary segments: Clinical Services and Enabling Services. The Clinical Services segment encompasses the full spectrum of clinical development, including phase I-IV trials, clinical pharmacology, and management of clinical studies. This segment is dedicated to advancing drug development through meticulous clinical trial management, leveraging cutting-edge technology to enhance the efficiency and effectiveness of trials.
The Enabling Services segment focuses on providing advanced solutions to facilitate the clinical trial process. This includes patient access services, which help in recruiting and retaining participants for trials, and clinical trial technology solutions that streamline randomization and optimize the drug supply chain. Fortrea Holdings offers various delivery models, such as full-service, functional service provider (FSP), and hybrid service structures, to cater to diverse client needs and project requirements.
Serving a wide array of clients, including pharmaceutical, biotechnology, and medical device companies, Fortrea Holdings aims to deliver integrated and technology-driven solutions. Its differentiated technology-enabled trial solutions and post-approval services are designed to address the complexities of modern clinical research and help clients achieve their development goals efficiently and effectively.
|
